Sg3 Management, LLC Kamada LTD Transaction History

Sg3 Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$4.12 - $5.25 $74,572 - $95,025	-18,100 Closed	0 $0
Q3 2022 May 15, 2023	BUY	$4.42 - $5.43 $80,002 - $98,283	18,100 New	18,100 $81,000
Q3 2022 Nov 14, 2022	SELL	$4.42 - $5.43 $17,238 - $21,177	-3,900 Reduced 17.73%	18,100 $82,000
Q2 2022 Aug 15, 2022	SELL	$4.22 - $5.85 $31,835 - $44,132	-7,544 Reduced 25.53%	22,000 $99,000
Q1 2022 May 16, 2022	SELL	$5.43 - $6.81 $54,397 - $68,222	-10,018 Reduced 25.32%	29,544 $163,000
Q4 2021 Feb 15, 2022	BUY	$5.21 - $6.82 $18,558 - $24,292	3,562 Added 9.89%	39,562 $260,000
Q3 2021 Nov 15, 2021	BUY	$5.25 - $5.87 $131,250 - $146,750	25,000 Added 227.27%	36,000 $191,000
Q2 2021 Aug 16, 2021	BUY	$5.67 - $6.33 $62,370 - $69,630	11,000 New	11,000 $64,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $260M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.